{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:02:32Z","timestamp":1794852152987,"version":"4.9.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Ferroptosis can have a major impact on the development and advancement of hepatocellular carcinoma (HCC) due to its clear association with heightened vulnerability to the disease. This study aimed to develop a novel nanoplatform to evaluate its effectiveness in\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      models of HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Erastin, a compound that induces iron-dependent cell death, and HMME, a sonosensitizer, were enclosed within mesoporous silica nanoparticles (MSNs). The nanoparticles were engineered to exhibit a responsive assembly-disassembly mechanism. Hydrophilic hyaluronic acid (HA) was utilized for conjugation modification to synthesize Erastin\/HMME@MSNs-HA.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      experiments were conducted to elucidate the antitumor mechanisms of this nanomaterial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the in vitro cellular experiments, Erastin\/HMME@MSNs-HA was rapidly degraded by hyaluronidase, leading to increased endocytosis of the cancer cells. Cellular breakdown led to the generation of harmful reactive oxygen species (ROS), decreased glutathione levels, and increased lipid peroxidation, resulting in a decrease in mitochondrial membrane potential, dysfunctional mitochondria, reduced cell growth, and increased cell death. Additionally, the Erastin\/HMME@MSNs-HA nanotherapy platform, when combined with ultrasound (US) treatment, exhibited significant therapeutic effectiveness against tumors\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      . It induced significant cell death in cancerous tissues, decreased tumor growth, worsened tissue oxygen deprivation, and exhibited good compatibility with the body.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings indicate that the nanoplatform can effectively alleviate tumor hypoxia while inducing apoptosis and ferroptosis, laying the foundation for enhancing the efficacy of ROS-mediated HCC therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1531_24","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:04:13Z","timestamp":1746237853000},"page":"465-476","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["MSNs-loaded HMME and Erastin-mediated ferroptosis combined with sonodynamic therapy for HCC treatment"],"prefix":"10.4103","volume":"21","author":[{"given":"Chang","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guchun","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niqiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, China"},{"name":"Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danke","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Imaging Center, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of hepatocellular carcinoma:A review","volume":"158","author":"Brown","year":"2023","journal-title":"JAMA Surg"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular carcinoma","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin Liver Dis"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3350\/cmh.2023.0106","article-title":"Management of hepatocellular carcinoma in China:Seeking common grounds while reserving differences","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/liv.15130","article-title":"Treatment and the prognosis of hepatocellular carcinoma in Asia","volume":"62","author":"Torimura","year":"2022","journal-title":"Liver Int"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.cgh.2023.01.039","article-title":"Breakthroughs in hepatocellular carcinoma therapies","volume":"21","author":"Singal","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2021.09.035","article-title":"Prognosis of patients with hepatocellular carcinoma treated with immunotherapy \u2013development and validation of the CRAFITY score","volume":"76","author":"Scheiner","year":"2022","journal-title":"J Hepatol"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4103\/jcrt.jcrt_2376_23","article-title":"Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma:A prospective clinical study","volume":"20","author":"Sun","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"e210037","DOI":"10.1001\/jamanetworkopen.2021.0037","article-title":"Cost-effectiveness of atezolizumab plus bevacizumab vs sorafenib as first-line treatment of unresectable hepatocellular carcinoma","volume":"4","author":"Su","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons:The role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"e6516","DOI":"10.1136\/jitc-2022-006516","article-title":"Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis","volume":"11","author":"Wang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"113374","DOI":"10.1016\/j.biopha.2022.113374","article-title":"An overview of ferroptosis in non-alcoholic fatty liver disease","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","article-title":"Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases","volume":"83","author":"Cui","year":"2023","journal-title":"Mol Cell"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Death Differ"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"188848","DOI":"10.1016\/j.bbcan.2022.188848","article-title":"Ferroptosis and its interaction with tumor immune microenvironment in liver cancer","volume":"1878","author":"Huang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"102122","DOI":"10.1016\/j.redox.2021.102122","article-title":"Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis","volume":"46","author":"Ren","year":"2021","journal-title":"Redox Biol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s11658-023-00449-6","article-title":"Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS","volume":"28","author":"Wang","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2023.03.001","article-title":"Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy","volume":"356","author":"Xu","year":"2023","journal-title":"J Control Release"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"e2204365","DOI":"10.1002\/advs.202204365","article-title":"Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"e2201884","DOI":"10.1002\/adhm.202201884","article-title":"Mesoporous silica nanoparticles-based nanoplatforms:Basic construction, current state, and emerging applications in anticancer therapeutics","volume":"12","author":"Feng","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"127060","DOI":"10.1016\/j.ijbiomac.2023.127060","article-title":"Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy","volume":"253","author":"Heidari","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10103-022-03529-9","article-title":"Hematoporphyrin monomethyl ether mediated photodynamic therapy inhibits oral squamous cell carcinoma by regulating the P53-miR-21-PDCD4 axis via singlet oxygen","volume":"37","author":"Meng","year":"2022","journal-title":"Lasers Med Sci"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"e2203106","DOI":"10.1002\/advs.202203106","article-title":"Intraparticle double-scattering-decoded sonogenetics for augmenting immune checkpoint blockade and CAR-T therapy","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"e1803549","DOI":"10.1002\/adma.201803549","article-title":"Hyaluronic acid\u2013based activatable nanomaterials for stimuli-responsive imaging and therapeutics:Beyond CD44-mediated drug delivery","volume":"31","author":"Choi","year":"2019","journal-title":"Adv Mater"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"121081","DOI":"10.1016\/j.carbpol.2023.121081","article-title":"Hyaluronic acid:More than a carrier, having an overpowering extracellular and intracellular impact on cancer","volume":"317","author":"Bhattacharyya","year":"2023","journal-title":"Carbohydr Polym"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijbiomac.2019.03.030","article-title":"Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy","volume":"130","author":"Ren","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/aps.2014.104","article-title":"Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic uptake of hematoporphyrin monomethyl ether isomers","volume":"36","author":"Li","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"102915","DOI":"10.1016\/j.pdpdt.2022.102915","article-title":"Enhanced permeability and retention effect:A key facilitator for solid tumor targeting by nanoparticles","volume":"39","author":"Shinde","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1039\/D0BM00408A","article-title":"A mitochondria-targeted anticancer nanoplatform with deep penetration for enhanced synergistic sonodynamic and starvation therapy","volume":"8","author":"Zhang","year":"2020","journal-title":"Biomater Sci"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"117938","DOI":"10.1016\/j.jep.2024.117938","article-title":"Shengjihuayu formula ameliorates the oxidative injury in human keratinocytes via blocking JNK\/c-Jun\/MMPs signaling pathway","volume":"326","author":"Sun","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"e84282","DOI":"10.7554\/eLife.84282","article-title":"Phosphate starvation signaling increases mitochondrial membrane potential through respiration-independent mechanisms","volume":"13","author":"Ouyang","year":"2024","journal-title":"Elife"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1:Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"Goenka","year":"2023","journal-title":"Cancer Commun"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00784-012-0792-3","article-title":"Comparison of different live\/dead stainings for detection and quantification of adherent microorganisms in the initial oral biofilm","volume":"17","author":"Tawakoli","year":"2013","journal-title":"Clin Oral Investig"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.2081fta","article-title":"TUNEL vision spots apoptotic cells","volume":"208","author":"Short","year":"2015","journal-title":"J Cell Biol"},{"issue":"(Supplement)","key":"R42-20250512","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.4103\/jcrt.jcrt_43_21","article-title":"Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix","volume":"19","author":"Mehdi","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","article-title":"HIF-1\u03b1 signaling:Essential roles in tumorigenesis and implications in targeted therapies","volume":"11","author":"Zhao","year":"2024","journal-title":"Genes Dis"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"101673","DOI":"10.1016\/j.nantod.2022.101673","article-title":"Therapeutic hydrogel for enhanced immunotherapy:A powerful combination of MnO2 nanosheets and vascular disruption","volume":"47","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"e2203227","DOI":"10.1002\/smll.202203227","article-title":"Metal-cyclic dinucleotide nanomodulator-stimulated STING signaling for strengthened radioimmunotherapy of large tumor","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-023-01974-4","article-title":"Next-generation nanomaterials:Advancing ocular anti-inflammatory drug therapy","volume":"21","author":"Wei","year":"2023","journal-title":"J Nanobiotechnology"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1531_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:44:56Z","timestamp":1787773496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1531_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1531_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-08-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}